No Data
No Data
Zacks.com Featured Highlights Include Argenx SE Alphatec and Olin
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading
Dianthus Started at Outperform by Oppenheimer on DNTH103 Opportunity
Halozyme Therapeutics Expands Licensing Agreement With Argenx
Morgan Stanley Maintains Argenx SE(ARGX.US) With Buy Rating, Maintains Target Price $580
Buy Rating Justified by Argenx Se's Promising Vyvgart Launch and Strong Sales Outlook
No Data
No Data